Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Medication Overuse Headache.

William B. Young1

  • 1Department of Neurology, The Thomas Jefferson University Hospital, Jefferson Headache Center, 111 South Eleventh Street, Gibbon Building, Suite 8130, Philadelphia, PA 19107, USA. william.b.young@mail.tju.edu

Current Treatment Options in Neurology
|February 17, 2001
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Alternative Therapies for Headache.

Current treatment options in neurologyยท2003
See all related articles

Medication overuse headache (MOH) affects 2% of the US population. Detoxification from butalbital and opioids has a higher relapse rate, and treatment setting consensus is lacking.

Area of Science:

  • Neurology
  • Clinical Pharmacology

Background:

  • Medication overuse headache (MOH) is a prevalent condition affecting 2% of the US population.
  • Various analgesics, including simple, caffeine-containing, butalbital-containing, opioids, ergotamine, and triptans, can trigger MOH.

Purpose of the Study:

  • To review the causes, treatment settings, and psychological aspects of medication overuse headache.
  • To highlight the differential recidivism rates following detoxification from various overused medications.

Main Methods:

  • Literature review of studies on medication overuse headache.
  • Analysis of treatment outcomes and patient psychological profiles.

Main Results:

  • Detoxification from butalbital-containing analgesics and opioids is associated with higher relapse rates compared to other substances.

Related Experiment Videos

  • Current treatment settings (home, infusion center, hospital) lack a consensus for optimal patient management.
  • Patients with MOH exhibit distinct psychological characteristics compared to psychiatric substance abusers.

    • Conclusions:

    • Psychiatric detoxification facilities are generally not suitable for treating patients with MOH.
    • Psychiatric assessment and support can be beneficial adjuncts in managing MOH patients.
    • Further research is needed to establish optimal treatment settings and protocols for MOH.